<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999073</url>
  </required_header>
  <id_info>
    <org_study_id>2017/260</org_study_id>
    <nct_id>NCT03999073</nct_id>
  </id_info>
  <brief_title>Carotid Atherosclerosis in Patients With Aortic Coarctation</brief_title>
  <acronym>CoA</acronym>
  <official_title>Carotid Atherosclerosis in Patients With Aortic Coarctation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skane University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skane University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite aortic coarctation (CoA) repair these patients have cardiovascular complications and
      coronary artery disease is the most common cause of death.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim with this study was to measure intima-media thickness (IMT) and plaques in arteries
      compared to cardiovascular markers in controls and patients with CoA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2012</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intima-media thickness</measure>
    <time_frame>Intima-media thickness will be measured at one time point namely at inclusion. Data will be reported when study is completed, an average of 2 year.</time_frame>
    <description>Measurement in mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular markers</measure>
    <time_frame>Blood samples will be taken at one time point namely at inclusion. Then biomarkers will be analysed when study is completed. Data will be reported when study is completed, an average of 2 year.</time_frame>
    <description>A multiplex platform to analyze circulating blood levels biomarkers was used.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">116</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Aortic Coarctation</condition>
  <arm_group>
    <arm_group_label>Subjects with coarctation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound measurement</intervention_name>
    <description>Ultrasound measurement</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Subjects with coarctation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aortic coarctation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sex and age-matched controls

        Exclusion Criteria:

          -  acute and chronic inflammation disease, underlying malignancies and diabetes mellitus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>sex and age-matched controls</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>June 24, 2019</last_update_submitted>
  <last_update_submitted_qc>June 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Skane University Hospital</investigator_affiliation>
    <investigator_full_name>Joanna Hlebowicz</investigator_full_name>
    <investigator_title>MD, Associated Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Aortic Coarctation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

